1,600
Views
20
CrossRef citations to date
0
Altmetric
Hemostasis and Thrombosis

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura

, , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Katerina Pavenski, Shih-Han Susan Huang & Christopher J. Patriquin. (2021) Predictors of relapse and preventative strategies in immune thrombotic thrombocytopenic purpura. Expert Review of Hematology 14:11, pages 1027-1040.
Read now
Andrés Gómez-De León, Luis Mario Villela-Martínez, José Miguel Yáñez-Reyes & David Gómez-Almaguer. (2020) Advances in the treatment of thrombotic thrombocytopenic purpura: repurposed drugs and novel agents. Expert Review of Hematology 13:5, pages 461-470.
Read now
Tugrul Elverdi & Ahmet Emre Eskazan. (2019) Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura. Drug Design, Development and Therapy 13, pages 1251-1258.
Read now
Wilma Barcellini & Bruno Fattizzo. (2018) Autoimmune hemolytic anemia - progress in emerging treatment options. Expert Opinion on Orphan Drugs 6:4, pages 273-282.
Read now

Articles from other publishers (16)

Lin Liu, Haitao Lu, Guming Zou, Haifeng Wang, Jing Li, Yue Yang, Jian Zhang, Xueling Wang, Wenge Li & Li Zhuo. (2023) Efficacy and safety of low-dose rituximab as induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement: a Chinese case series. BMC Nephrology 24:1.
Crossref
M. Subhan & M. Scully. (2022) Advances in the management of TTP. Blood Reviews 55, pages 100945.
Crossref
César David Galindo-Calvillo, Carlos Saúl Rodríguez-Roque, Andrés Gómez-De León, Luz Tarín-Arzaga & David Gómez-Almaguer. (2021) Treating thrombotic thrombocytopenic purpura without plasma exchange during the COVID-19 pandemic. A case report and a brief literature review. Transfusion and Apheresis Science 60:3, pages 103107.
Crossref
Amalia Domingo‐González, Isabel Regalado‐Artamendi, Reyes María Martín‐Rojas, Gloria Pérez‐Rus, Ana Pérez‐Corral, José Luis Díez‐Martín & Cristina Pascual‐Izquierdo. (2021) Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at a tertiary care facility in Spain . Journal of Clinical Apheresis 36:3, pages 420-428.
Crossref
Manasa S. Reddy, Sandra Hofmann, Yu Min Shen, Srikanth Nagalla, Siayareh Rambally, Amena Usmani & Ravi Sarode. (2020) Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission. Transfusion and Apheresis Science 59:6, pages 102885.
Crossref
George Goshua, Amit Gokhale, Jeanne E. Hendrickson, Christopher Tormey & Alfred Ian Lee. (2020) Cost savings to hospital of rituximab use in severe autoimmune acquired thrombotic thrombocytopenic purpura. Blood Advances 4:3, pages 539-545.
Crossref
Adrien Picod & Paul Coppo. (2019) When targeted therapies alleviate the burden of TPE: The example of immune-mediated TTP. Transfusion and Apheresis Science 58:3, pages 273-277.
Crossref
Emmanuel Bugarin-Estrada, Andrés Gómez-De León, Yadith Karina López-García, Erik Alejandro Díaz-Chuc, José Manuel Priesca-Marín, Guillermo J. Ruiz-Argüelles, José Carlos Jaime-Pérez & David Gómez-Almaguer. (2018) Clinical presentation in thrombotic thrombocytopenic purpura: Real-world data from two Mexican institutions. Journal of Clinical Apheresis 33:6, pages 645-653.
Crossref
Rurong Sun, Weiying Gu, Yingchun Ma, Jing Wang & Min Wu. (2018) Relapsed/refractory acquired thrombotic thrombocytopenic purpura in a patient with Sjögren syndrome. Medicine 97:43, pages e12989.
Crossref
. 2018. Diagnostic Pathology: Blood and Bone Marrow. Diagnostic Pathology: Blood and Bone Marrow 306 309 .
Johanna A. Kremer Hovinga, Paul Coppo, Bernhard Lämmle, Joel L. Moake, Toshiyuki Miyata & Karen Vanhoorelbeke. (2017) Thrombotic thrombocytopenic purpura. Nature Reviews Disease Primers 3:1.
Crossref
J. Evan Sadler. (2017) Pathophysiology of thrombotic thrombocytopenic purpura. Blood 130:10, pages 1181-1188.
Crossref
P. Coppo. (2017) Management of thrombotic thrombocytopenic purpura. Transfusion Clinique et Biologique 24:3, pages 148-153.
Crossref
M. Patient, P. Fuseau & C. Deligny. (2017) Le purpura thrombotique thrombocytopénique à la Martinique : étude rétrospective entre 2008 et 2015. La Revue de Médecine Interne 38:8, pages 508-512.
Crossref
C. Vigneron & A. Hertig. (2017) Micro-angiopathies thrombotiques du péripartum : physiopathologie, diagnostic et traitementPeripartum thrombotic micro-angiopathies: Pathophysiology, diagnosis and treatment. Médecine Intensive Réanimation.
Crossref
Haifei Chen, Ailin Fu, Jing Wang, Tianqin Wu, Zhengyang Li, Jieqing Tang, Hongshi Shen, Jingjing Zhu, Jie Li, Qian Zhu & Longmei Qing. (2017) Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura. Journal of International Medical Research 45:3, pages 1253-1260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.